
Telmilib Amh 40mg/5mg/12.5mg Tablet
Marketer
Libramed Pharmaceuticals Private Ltd
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Chlorthalidone (12.5mg)
Overview Telmilib Amh 40mg/5mg/12.5mg Tablet
Amh-Tel 40mg/5mg/12.5mg tablets combine medications to manage hypertension when single-drug therapy proves insufficient. This formulation lowers elevated blood pressure, mitigating the risk of future strokes and heart attacks. Ingestion should occur with food, dosage tailored to individual response and condition. Consistent daily timing is advised; continuous use is crucial unless otherwise directed by your physician. The diuretic component may increase urination, hence avoid consumption within four hours of bedtime. Regular use, even during symptom absence, maximizes therapeutic benefits; cessation elevates stroke and heart attack risks. Common side effects encompass ankle swelling, headache, dizziness, fatigue, and altered taste perception. Report persistent, worsening, or troublesome side effects to your doctor. Ample fluid intake counteracts potential dryness, thirst, and muscle weakness. Prior to commencement, disclose any kidney or liver ailments. Pregnant or lactating individuals should seek medical counsel. Full disclosure of concurrent medications, especially those for hypertension or cardiac conditions, is mandatory. Regular monitoring of blood pressure, kidney function, electrolyte levels, and blood glucose is essential to ensure optimal treatment efficacy.
Uses of Telmilib Amh 40mg/5mg/12.5mg Tablet
Elevated blood pressure
Major Benefits of Telmilib Amh 40mg/5mg/12.5mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the Telmilib Amh 40mg/5mg/12.5mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
Common Side effects of Telmilib Amh 40mg/5mg/12.5mg Tablet:
- Headache
- Dizziness
- Sleepiness
- Edema (swelling)
- Increased uric acid level in blood
- Fatigue
- Increased blood lipid level
- Increased liver enzymes
- Visual disturbance
- Breathlessness
- Muscle cramp
- Gastrointestinal disturbance
- Electrolyte imbalance
- Increased glucose level in blood
- Urticaria
- Postural hypotension (low blood pressure)
- Impotence
How to use Telmilib Amh 40mg/5mg/12.5mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the Telmilib Amh 40mg/5mg/12.5mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
How Telmilib Amh 40mg/5mg/12.5mg Tablet works:
Telmisartan 40mg/Amlodipine 5mg/Chlorthalidone 12.5mg tablets, branded as Telmilib Amh, contain three active ingredients that work synergistically to control hypertension. Telmisartan, an angiotensin II receptor antagonist, and amlodipine, a calcium channel blocker, both promote vasodilation, reducing vascular resistance and consequently blood pressure. Chlorthalidone, a thiazide diuretic, increases urinary excretion of sodium and water, further lowering blood pressure and enhancing the effects of the other components.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Telmilib Amh 40mg/5mg/12.5mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Telmilib Amh 40mg/5mg/12.5mg tablets during pregnancy is contraindicated due to established fetal risks. In exceptional circumstances involving life-threatening conditions, a physician might prescribe it if the potential benefits outweigh the hazards. Seek medical advice before use.
Breast feedingSAFE IF PRESCRIBED
The use of Telmilib Amh 40mg/5mg/12.5mg tablets while breastfeeding is likely safe. Preliminary human studies indicate minimal risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Telmilib Amh 40mg/5mg/12.5mg Tablet side effects. These potential side effects include dizziness, headache, nausea, or fatigue, each capable of reducing concentration and safe driving.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Telmilib Amh 40mg/5mg/12.5mg tablets. Dosage modification may be necessary; physician consultation is advised. This medication is generally not recommended for such patients.
LiverCAUTION
Patients with liver impairment should use Telmilib Amh 40mg/5mg/12.5mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Telmilib Amh 40mg/5mg/12.5mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Telmilib Amh 40mg/5mg/12.5mg Tablet :
Should you forget a Telmilib Amh 40mg/5mg/12.5mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telmilib Amh 40mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
